Skip to main content
Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.630
-0.300 (-6.09%)
Jun 12, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Novel Antibody-based Therapeutic Products
85.19M
Log In
Log In
Log In
Log In
Novel Antibody-based Therapeutic Products Growth
1.03%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
65.98M
Log In
Log In
Log In
Log In
United States Growth
-2.70%
Log In
Log In
Log In
Log In
Eastern Asia
7.46M
Log In
Log In
Log In
Log In
Latin America
4.72M
Log In
Log In
Log In
Log In
Western Asia
4.05M
Log In
Log In
Log In
Log In
Western Europe
2.09M
Log In
Log In
Log In
Log In
Other Regions
890.00K
Log In
Log In
Log In
Log In
Other Regions Growth
-94.61%
Log In
Log In
Log In
Log In